Pulike Biological Engineering, Inc. (SHA:603566)
14.53
+0.08 (0.55%)
Sep 15, 2025, 2:45 PM CST
SHA:603566 Revenue
Pulike Biological Engineering had revenue of 280.81M CNY in the quarter ending June 30, 2025, with 13.38% growth. This brings the company's revenue in the last twelve months to 1.12B, up 0.09% year-over-year. In the year 2024, Pulike Biological Engineering had annual revenue of 1.04B, down -16.77%.
Revenue (ttm)
1.12B
Revenue Growth
+0.09%
P/S Ratio
4.43
Revenue / Employee
721.37K
Employees
1,551
Market Cap
4.96B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.04B | -210.13M | -16.77% |
Dec 31, 2023 | 1.25B | 22.62M | 1.84% |
Dec 31, 2022 | 1.23B | 131.50M | 11.97% |
Dec 31, 2021 | 1.10B | 170.06M | 18.31% |
Dec 31, 2020 | 928.51M | 265.32M | 40.01% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 30.15B |
WuXi AppTec | 41.90B |
Shenzhen Mindray Bio-Medical Electronics | 32.94B |
Sichuan Biokin Pharmaceutical | 441.19M |
Shanghai United Imaging Healthcare | 10.98B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.52B |
Aier Eye Hospital Group | 21.94B |
Yunnan Baiyao Group Co.,Ltd | 40.84B |